Carle Cancer Institute

Carle Cancer Institute is the premier cancer treatment and support center in east central Illinois, offering more resources to help patients in the fight against cancer. With the area's largest and most specialized team of fellowship trained oncologists, surgeons and staff, patients get in for diagnosis and start treatment as soon as possible. Our team offers the latest technology and highly specialized multidisciplinary clinics for certain cancers, including breast, prostate, gynecologic, and head and neck. But we don't just treat a disease – we care for the whole patient, offering support groups, genetic and nutrition counseling, nurse navigator services and more.

FIND A DOCTOR DONATE NOW

Mills Breast Cancer Institute

Mills Breast Cancer Institute was built on a vision of providing expert care close to home.

FIND A DOCTOR LEARN MORE

Clinics and Programs

Breast Cancer

Our experts in oncology, breast imaging, reconstructive surgery, genetics, research and support services, give you the tools you need in the fight against breast cancer.

Gastrointestinal Cancers

With a team approach to care, experts at Carle Cancer Institute develop an individualized plan of treatment for patients with gastrointestinal cancer.

Gynecological Cancers

Carle gynecologic oncology team serves women who have or are suspected of having ovarian, cervical, endometrial, and vulvar cancers.

Head and Neck Cancers

The Carle Cancer Institute focuses on aggressive and effective treatment, helping to instill hope in patients undergoing what is often an unknown journey.

Lung/Thoracic Cancer

With a team approach to care, experts at Carle Cancer Institute develop an individualized plan of treatment for patients with lung cancer.

Lymphoma/Leukemia

With a team approach to care, experts at Carle Cancer Center develop an individualized plan of treatment for patients with lymphoma and leukemia.

Skin Cancer

Experts at Carle Cancer Institute along with Dermatology and Plastic Surgery experts develop and individualized plan for patients with skin cancer.

Urologic Cancers

Our urologic cancer practice is based on a multi-specialty approach that combines clinical expertise from urology and radiation oncology.

Have a patient referral? Refer a patient now.

Research and Clinical Trials

Involved in national research for more than 30 years, Carle Cancer Institute offers its patients access to innovative ways to fight cancer through clinical trials. Clinical trials offer new insight into how to combat a disease like cancer and demonstrate new ways of preventing, treating, or possibly curing cancer.

Carle Cancer Institute provides access to clinical trials for several types of cancer including but not limited to breast, lung, colon, melanoma, prostate, and ovarian cancer. We are also actively involved in national prevention clinical trials per cancer type. In addition, we offer symptom management program to address the quality of life of cancer patients.

Molecular Analysis for Therapy Choice (MATCH)

This phase II trial studies how well treatment that is directed by genetic testing works in patients with solid tumors or lymphomas that have progressed following at least one line of standard treatment or for which no agreed upon treatment approach exists. Genetic tests look at the unique genetic material (genes) of patients' tumor cells. Patients with genetic abnormalities (such as mutations, amplifications, or translocations) may benefit more from treatment which targets their tumor's particular genetic abnormality. Identifying these genetic abnormalities first may help doctors plan better treatment for patients with solid tumors or lymphomas.

Docetaxel or Paclitaxel in Reducing Chemotherapy-Induced Peripheral Neuropathy in African American Patients With Stage I-III Breast Cancer

This phase II trial studies how well docetaxel or paclitaxel work in reducing chemotherapy-induced peripheral neuropathy in African American patients with stages I-III breast cancer. Drugs used in chemotherapy, such as docetaxel and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. It is not yet known whether giving docetaxel or paclitaxel may work better than other methods in reducing chemotherapy-induced peripheral neuropathy in patients with breast cancer.

A Study of VB-111 With Paclitaxel vs Paclitaxel for Treatment of Recurrent Platinum-Resistant Ovarian Cancer (OVAL)

The purpose of this phase 3, randomized, multicenter study is to compare VB-111 and paclitaxel to placebo and paclitaxel in adult patients with Recurrent Platinum-Resistant Ovarian Cancer.

SEE MORE CLINICAL TRIALS

Meet Our Team

With doctors practicing in 80 specialties at locations throughout the region, it’s easy to find the right healthcare team at Carle. Our mission is to serve people through high quality care, medical research and education.

MEET OUR TEAM

Giving

Charitable gifts are used for numerous projects and programs that enhance the healthcare experience for cancer patients and their loved ones. With your support, we’ll continue to work to eliminate cancer through excellence in diagnosis, treatment, research and education.

DONATE NOW GIVING AT CARLE

Research and philanthropy drive decade of cancer center progress

Parking lot becomes world-class cancer center where the way people are treated is just as important as the treatment.

DONATE NOW READ FULL ARTICLE

Zoom: Advance Care Planning

March 3, 2021
11:30 a.m.

Zoom: IBD Support Group

March 3, 2021
6 p.m.

Virtual: Life After Loss, Introduction to Grief

March 3, 2021
6 p.m.

Awards and Accreditations

Recognized among the nation’s top hospitals, Carle provides excellent healthcare while continuously improving to meet the needs of our patients.

Cancer

Digestive Health

Pediatric Conditions

Heart and Vascular

Neurosciences Conditions

Women's Conditions

Cancer Center

Heart and Vascular Institute

Pediatric Care

Women's Health Institute

Digestive Health Institute

Neuroscience Institute

Research Institute

Community Health Initiatives